1st trial interim readout is not even until next y
Post# of 144505
![](/assets/46931549/no_avatar_available_thumb.jpg)
Noone is going to attempt a buyout before then.
Which if so, they won't use their cash on hand.
Good example --- when DeBeers went private.
Look @ what the loan to assets ratio was.
LL MOA proof & patents validated = serious $$.
Also keep an eye out for more patent approvals.
Dr. J said raising funding & planning for 2 trials.
That's all that needs to be enjoyed for now.
Cytodyn's moving forward plans.
Simple.
Shall see....
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)